• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MAP 0.00% 19.0¢

MICROBA LIFE SCIENCES LIMITED

Microba Life Sciences Limited is an Australia-based precision microbiome company. The... Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for major chronic diseases and delivers gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Through its analysis and discovery platforms, it identifies microbiome-derived therapeutics and diagnostic tools to advance medicine. Through its Analysis Platform, it generates a global databank of microbiome samples and associated metadata to develop new health solutions. Its Discovery Platform enables partners to access this databank for the data-driven discovery of product opportunities. Its therapeutic platform is a repeatable platform for microbial therapeutic leads. It also offers a product portfolio of gastrointestinal, vaginal, oral, and urinary microbiome testing, together with a targeted set of evidence-based formulations. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MAP
News: MAP Microba Life Sciences Posts A$4.81 Mln Q4 Fy24 Unaudited Revenue
25/07/24 0 264
25/07/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  264 
MAP 25/07/24 1 721
25/07/24 Last post  seahunt Comments Created with Sketch.  1  Views Created with Sketch.  721 
MAP 25/07/24 0 349
25/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  349 
MAP 23/07/24 0 181
23/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  181 
MAP 19/07/24 2 1.0K
19/07/24 Last post  seahunt Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
MAP 10/07/24 0 204
10/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  204 
MAP 01/07/24 9 3.1K
01/07/24 Last post  708trader Comments Created with Sketch.  9  Views Created with Sketch.  3.1K 

See All Discussions arrow Created with Sketch.

Timeline

Q4 FY24 Quarterly Investor Presentation & Webinar
25 Jul 09:11
 
Q4 FY24 Quarterly Activities Report & Appendix 4C
25 Jul 09:04
 
Details of Q4 FY24 Quarterly Report, Appendix 4C & Webinar
23 Jul 09:03
 
Microba Diagnostics Business Update to Bioshares Summit
12 Jul 09:18
 
Notification of cessation of securities - MAP
10 Jul 17:33
 
Completion of Autoimmune Program with Ginkgo Bioworks
28 Jun 09:02
 
View More arrow Created with Sketch.
(20min delay)
Last
19.0¢
Change
0.000(0.00%)
Mkt cap ! $85.09M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 2700 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 91683 1
View Market Depth
Last trade - 07.02am 26/08/2024 (20 minute delay) ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.